Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Foods ; 9(9)2020 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-32825524

RESUMO

Food-derived bioactive peptides offer great potential for the treatment and maintenance of various health conditions, including chronic inflammation. Using in vitro testing in human macrophages, a rice derived functional ingredient natural peptide network (NPN) significantly reduced Tumour Necrosis Factor (TNF)-α secretion in response to lipopolysaccharides (LPS). Using artificial intelligence (AI) to characterize rice NPNs lead to the identification of seven potentially active peptides, the presence of which was confirmed by liquid chromatography tandem mass spectrometry (LC-MS/MS). Characterization of this network revealed the constituent peptides displayed anti-inflammatory properties as predicted in vitro. The rice NPN was then tested in an elderly "inflammaging" population with a view to subjectively assess symptoms of digestive discomfort through a questionnaire. While the primary subjective endpoint was not achieved, analysis of objectively measured physiological and physical secondary readouts showed clear significant benefits on the ability to carry out physical challenges such as a chair stand test that correlated with a decrease in blood circulating TNF-α. Importantly, the changes observed were without additional exercise or specific dietary alterations. Further health benefits were reported such as significant improvement in glucose control, a decrease in serum LDL concentration, and an increase in HDL concentration; however, this was compliance dependent. Here we provide in vitro and human efficacy data for a safe immunomodulatory functional ingredient characterized by AI.

2.
JSLS ; 9(2): 174-7, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15984705

RESUMO

OBJECTIVES: This study was undertaken to determine the actual amount of time a dynamic fluoroscopic intraoperative cholangiogram adds to a laparoscopic cholecystectomy. A secondary objective was to define the information gained from this procedure. METHODS: A consecutive case study of 52 patients undergoing laparoscopic cholecystectomy was used. Time was recorded from placement of a laparoscopic hemoclip across the cystic duct at its junction with the gallbladder until successful completion of the intraoperative cholangiogram. The mean, median, and range of times for these cases, as well as the results and false-negative rates, were determined. RESULTS: Cholangiography was successfully completed in 96% of patients. The mean time added to laparoscopic cholecystectomy by the addition of dynamic fluoroscopic intraoperative cholangiography was 4.3 minutes. The median time was 3.0 minutes. The times ranged from 2.0 minutes to 16.0 minutes. Choledocholithiasis was present in 15.4% of these patients. The false-positive rate was zero in this study. CONCLUSIONS: Dynamic fluoroscopic intraoperative cholangiogram was fast and efficient. The information gained was significant in that 15% of patients proceeded on to laparoscopic common bile duct exploration. We conclude that intraoperative cholangiography should be a routine addition to laparoscopic cholecystectomy.


Assuntos
Colangiografia/métodos , Colecistectomia Laparoscópica , Fluoroscopia , Humanos , Período Intraoperatório , Estudos Prospectivos , Fatores de Tempo
3.
J Pediatr ; 144(4): 471-9, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15069395

RESUMO

OBJECTIVE: To test the efficacy and safety of long-chain polyunsaturated fatty acid (LCPUFA) supplementation with gamma-linolenic acid, a precursor of arachidonic acid, and docosahexaenoic acid in preterm infants. STUDY DESIGN: Preterm (<35 weeks, < or =2000 g birth weight) infants (n=238) randomly assigned to unsupplemented or LCPUFA-supplemented formula to 9 months after term. The main outcome measure was the Bayley Mental and Psychomotor Indexes (MDI, PDI) at 18 months after term. Safety outcome measures were anthropometry (9 and 18 months), feed tolerance, infection, and clinical complications. RESULTS: There were no significant differences in neurodevelopment between groups overall. In preplanned subgroup analyses, LCPUFA-supplemented boys had significantly higher Bayley MDI than did control boys (difference, 5.7 points; 95% CI, 0.3 to 11.1; P=.04). LCPUFA-supplemented infants showed significantly greater weight gain (difference, 310 g; 95% CI, 30 to 590 g; P=.03) and length gain (difference, 1.0 cm; 95% CI, 0.02 to 1.9; P=.05) between birth and 9 months, with greater effect in boys (weight difference at 9 months, 510 g; 95% CI, 80 to 930 g; P=.02; length difference at 18 months, 1.8 cm; 95% CI, 0.1 to 1.8; P=.03). CONCLUSIONS: This trial, using the strategy of providing gamma-linolenic acid as a source of arachidonic acid, showed efficacy for growth and for neurodevelopment in boys, with no adverse effects. These data have important implications for LCPUFA-supplementation strategy in preterm infants.


Assuntos
Ácidos Docosa-Hexaenoicos/administração & dosagem , Ácido Eicosapentaenoico/administração & dosagem , Fórmulas Infantis/química , Recém-Nascido Prematuro , Ácido gama-Linolênico/administração & dosagem , Estatura/fisiologia , Cognição/fisiologia , Método Duplo-Cego , Feminino , Humanos , Lactente , Fenômenos Fisiológicos da Nutrição do Lactente/fisiologia , Recém-Nascido , Masculino , Leite Humano , Desempenho Psicomotor/fisiologia , Fatores Sexuais , Aumento de Peso
4.
Trib. méd. (Bogotá) ; 87(4): 174-9, abr. 1993. tab
Artigo em Espanhol | LILACS | ID: lil-183501

RESUMO

Se han hecho recomendaciones contradictorias con respecto a si las madres VIH positivas deben amamantar. Debido a que los paises en desarrollo suelen imitar las prácticas estadounidenses para la alimentación de los lactantes, se creó un modelo para calcular la mortalidad infantil en regiones menos desarrolladas, donde se observa la advertencia de los Centros de los EE.UU. para el control de Enfermedades de que las madres VIH positivas no deben amamantar. En este modelo se dan estimaciones para la mortalidad infantil con y sin lactancia materna, en varios niveles de referencia y de tasas teóricas de transmisión por medio de la lactancia. Se considera que la mortalidad infantil asociada con la infección por el VIH contraída a travez de la leche materna, es más baja que la mortalidad asociada con las enfermedades de la infancia que resultarían de suspender la leche materna. La diferencia entre estas apreciaciones es mayor en las zonas que presentan niveles altos de mortalidad infantil.


Assuntos
Humanos , Feminino , Lactente , Aleitamento Materno , HIV/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA